We serve Chemical Name:Anagrelide CAS:68475-42-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Anagrelide
CAS.NO:68475-42-3
Synonyms:[14C]-Anagrelide;BL 4162A;Anagrelide (INN/BAN);6,7-di-chloro-1,5-dihydroimidazo[2,1-b]quinazolin-2[3 H ]-one base;Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-5,10-dihydro-;Anagrelida;UNII-K9X45X0051;6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one;Anagrelide;6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one;Anagrelidum;6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one;Anagrelidum [INN-Latin];Agrelin;MFCD00866794;6,7-dichloro-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one;6,7-Dichloro-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one;Anagrelida [INN-Spanish]
Molecular Formula:C10H7Cl2N3O
Molecular Weight:256.088
HS Code:2933990090
Physical and Chemical Properties:
Melting point:280 °C
Boiling point:376.5±52.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.791
PSA:44.70000
Exact Mass:254.996613
LogP:1.96
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3163
Packing Group:
Contact us for information like [14C]-Anagrelide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Anagrelida [INN-Spanish] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-5,10-dihydro- Use and application,6,7-Dichloro-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one technical grade,usp/ep/jp grade.
Related News: As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. 1-Propyl-2-pyrrolidinone manufacturers Plexxikon filed a lawsuit against the pharma giant in 2017, alledging that Tafinlar, a rival to its melanoma drug Zelboraf that was brought to market in collaboration with Roche, has stepped on its intellectual property. The jury ruled in its favor, adding that the infringement is in fact willful. N-Amyl-N-methylnitrosamine suppliers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. 2-[(4-methyl-1,2,5-oxadiazole-3-carbonyl)amino]acetic acid vendor & factory.
